Why the study?
To review cardiac immune cell heterogeneity during homeostasis, how populations change in response to injury such as myocardial infarction or pressure overload, and the regulating stimuli.
Key points are not available for this paper at this time.
Design
Review
Highlights cardiac immune heterogeneity as a research frontier; leaves open clinical translation and therapeutic targeting.
During homeostasis, immune cells perform daily housekeeping functions to maintain heart health by acting as sentinels for tissue damage and foreign particles. Resident immune cells compose 5% of the cellular population in healthy human ventricular tissue. In response to injury, there is an increase in inflammation within the heart due to the influx of immune cells. Some of the most common immune cells recruited to the heart are macrophages, dendritic cells, neutrophils, and T-cells. In this review, we will discuss what is known about cardiac immune cell heterogeneity during homeostasis, how these cell populations change in response to a pathology such as myocardial infarction or pressure overload, and what stimuli are regulating these processes. In addition, we will summarize technologies used to evaluate cell heterogeneity in models of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Corker et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: